Breast Cancer Stage Clinical Trial
Official title:
A Real-world Study of Paclitaxel Injection (Albumin-bound) for Neoadjuvant Treatment of Breast Cancer
Neoadjuvant chemotherapy is a systemic cytotoxic drug therapy for non-metastatic tumors before local therapy, Now it has become an important part of standard treatment for a stage II, III, and the first clinical Ⅳ breast cancer .Both domestic and foreign authoritative guidelines recommend the use of albumin-binding paclitaxel in the neoadjuvant treatment of breast cancer .In addition, clinical studies at home and abroad have preliminarily confirmed the application value and therapeutic benefit of albumin-binding paclitaxel in breast cancer neoadjuvant therapy, and the toxic and side effects can be tolerated.
Data were collected on the efficacy and safety of neoadjuvant therapy in patients receiving albumin-binding taxol regimens,Subgroup analysis was performed for different treatment regimens, dosages, molecular subtypes and tumor stages,To further screen the dominant population and the chemotherapy regimen with clinical benefit of albumin paclitaxel, so as to provide evidence-based medical evidence for breast cancer neoadjuvant clinical diagnosis and treatment. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT04741204 -
Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer
|
Phase 4 | |
Completed |
NCT04929964 -
COVID-19 Pandemic: Effect on Management of Patients With Breast Cancer
|
||
Completed |
NCT05463276 -
The Characteristics and Risk Factors of Breast Cancer Patients Trend Distinctive Regional Differences: a Cross-sectional Study
|
||
Active, not recruiting |
NCT06234488 -
Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study
|
||
Completed |
NCT03530696 -
T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer
|
Phase 2 | |
Recruiting |
NCT05190770 -
A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer
|
Phase 2 | |
Recruiting |
NCT05142800 -
Screening For BCRL In Targeted Therapy For Breast Cancer
|
||
Completed |
NCT05022602 -
Clinical Evaluation of Opto-Acoustic Image Quality With the Gen 2 Imagio System
|
N/A |